Novartis is growing in oncology, but its moves to develop targeted cancer therapies had steered clear of antibody drug conjugates, one of the most active areas of cancer research and …
Category:
Health
-
-
Many of the healthcare AI tools hitting the market in the past few years have been built to lighten the load on clinicians — with less attention being paid to …
-
It’s well known that private equity has drastically increased its presence in the healthcare industry, acquiring hospitals, physician practices and other providers. These acquisitions have received scrutiny following the bankruptcies …
-
Oncology remains one of the most challenging areas for payers since it is literally in the eye of a perfect storm of expensive medications, high-cost specialized therapies, changing reimbursement rules …
-
One of the standard treatments for idiopathic pulmonary fibrosis is an old drug that offers limited efficacy and a range of side effects. Celea Therapeutics aims to offer advantages over …
-
Medicaid programs are in a period of heightened scrutiny, as states confront growing complexity in how these programs are administered and sustained. A recent Kaiser Family Foundation analysis highlights how …
-
Whenever people think of at-home care, generally it’s tied to remote monitoring or at-home diagnostics or temporary hospital-at-home programs. But at-home care now includes palliative care. In this month’s pivot …
-
The case for AI-powered documentation tools has moved from theory to data. By mid-2025, 62.6 percent of U.S. hospitals running Epic had deployed some form of ambient AI scribing, according …
-
Healthcare workforce strategy has long centered on reducing, responding to and recovering from turnover. That’s certainly true for organizations that employ allied health professionals, where turnover costs amount to $14,200 …
-
Almost every healthcare AI pilot I have seen clear its success criteria has gone on to struggle in production, sometimes within months of going live, and almost always for reasons …